Nutra Pharma Corp (NPHC)

[eZ3]

That's mostly speculative.

Inventory means nothing if they can't sell it. If they don't sell the inventory it's just more debt.

Company needs to get sales with the pet spray and nyoxlyn (sorry for the spelling).

Then they need the drugs in the pipeline that are in trials to get approved and hopefully licensed.

If they can pull that off we got a monster winner but make no mistake if they don't execute what I just wrote than continued debt and convertible notes will kill this.

Let's also keep in mind that they are competing with BIG PHARMA too. Hopefully they can license to BIG PHARMA as opposed to competing with them.

I do think this is a worthwhile risk with huge reward potential so I'm hoping for the best for all of us